Search earnings tickers

VRTX

2024Q4AMC

Vertex Pharmaceuticals Inc primary · HEALTHCARE · BIOTECHNOLOGY

Report 2025-02-10 · Fiscal end 2024-12-31 · Features as of 2025-02-10

← Earnings history

Street

Consensus EPS4.02

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move2.1%

IV front—

P/C full—

P/C front—

Features as of2025-02-10

Run-up

Close—

Ret 5d-0.1%

Ret 10d+5.9%

Ret 20d+14.7%

Ret 30d+15.1%

Print

Actual EPS

3.98Miss

Estimated EPS4.02

Actual revenue

2.9B

Surprise %-1.0%

Beat / missMiss

Beat streak 40

Beat streak 80

Reaction

1-day stock reaction-1.0%

Implied vs actual

Implied 2.1%Actual 2.2%

Gap reaction-2.2%

Day result-3.1%

Next-day upNo

Realized / IV1.03×

Post tape

Post 5d+3.6%

Post 10d+5.2%

Post volume1.6M

Vol ×10d0.93×

Vol ×20d0.96×

Post range3.4%